10 papers analyzed
Some studies suggest CBD reduces anxiety in various disorders, while other studies indicate insufficient evidence and minimal effects in healthy adults.
19 papers analyzed
Cannabidiol (CBD), a non-psychoactive compound found in cannabis, has garnered significant interest for its potential anxiolytic (anxiety-reducing) properties. This synthesis aims to evaluate the current evidence on the efficacy of CBD in reducing anxiety, based on findings from various research studies.
General Anxiolytic Effects of CBD:
Mechanisms and Brain Activity:
Efficacy in Specific Anxiety Disorders:
Comparison with Placebo:
Safety and Tolerability:
Limitations and Need for Further Research:
The current body of research suggests that CBD has significant potential as an anxiolytic agent, particularly for social anxiety disorder and generalized anxiety disorder. It appears to be effective in reducing anxiety symptoms and is generally well-tolerated with minimal adverse effects. However, further research is needed to establish standardized dosing protocols and to explore the long-term efficacy and safety of CBD in treating various anxiety disorders.
What are the latest treatments for acne scars?
research about technology - asean
amphibians reptiles endangered
Is technology changing our circadian rhythm?
repurchase intention
Does HMB improve protein balance in muscles?